CYTEIR THERAPEUTICS Trademark

Trademark Overview

On Thursday, July 11, 2019, a trademark application was filed for CYTEIR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CYTEIR THERAPEUTICS trademark a serial number of 88510194. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 22, 2023. This trademark is owned by Cyteir Therapeutics, Inc.. The CYTEIR THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical testing for diagnostic or treatment services; medical testing services for developing personalized therapies

Research and development of medical tests for analyzing synthetic lethality and DNA damage; research and development of synthetic lethal therapies and biomarkers of synthetic lethality; medical laboratory services; medical testing for scientific research purposes in the field of oncology, synthetic lethality, and DNA repair; providing medical and scientific research information in the fields of synthetic lethality, DNA repair, synthetic lethal therapies, oncology, hematology, and immunology; drug discovery services
cyteir therapeutics

General Information

Serial Number88510194
Word MarkCYTEIR THERAPEUTICS
Filing DateThursday, July 11, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 22, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Description of MarkThe mark consists of a circular pattern of dots resembling a starburst design, and the words "CYTEIR THERAPEUTICS" stacked to the right of the design on two lines of black font text, with the text on the first line in slightly larger font.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical testing for diagnostic or treatment services; medical testing services for developing personalized therapies
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development of medical tests for analyzing synthetic lethality and DNA damage; research and development of synthetic lethal therapies and biomarkers of synthetic lethality; medical laboratory services; medical testing for scientific research purposes in the field of oncology, synthetic lethality, and DNA repair; providing medical and scientific research information in the fields of synthetic lethality, DNA repair, synthetic lethal therapies, oncology, hematology, and immunology; drug discovery services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 18, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 18, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCyteir Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameCyteir Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, May 22, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 22, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU EXTENSION 5 GRANTED
Thursday, October 13, 2022SOU EXTENSION 5 FILED
Thursday, October 13, 2022TEAS EXTENSION RECEIVED
Friday, April 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2022SOU EXTENSION 4 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 4 FILED
Wednesday, April 20, 2022TEAS EXTENSION RECEIVED
Friday, September 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 8, 2021SOU EXTENSION 3 GRANTED
Wednesday, September 8, 2021SOU EXTENSION 3 FILED
Wednesday, September 8, 2021TEAS EXTENSION RECEIVED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021CORRECTED NOA E-MAILED
Tuesday, June 15, 2021SOU EXTENSION 2 GRANTED
Monday, March 1, 2021SOU EXTENSION 2 FILED
Tuesday, June 15, 2021DIVISIONAL PROCESSING COMPLETE
Monday, March 1, 2021DIVISIONAL REQUEST RECEIVED
Monday, June 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 15, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 1, 2021TEAS REQUEST TO DIVIDE RECEIVED
Monday, March 1, 2021TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 18, 2020SOU EXTENSION 1 GRANTED
Friday, September 18, 2020SOU EXTENSION 1 FILED
Friday, September 18, 2020TEAS EXTENSION RECEIVED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 27, 2019NON-FINAL ACTION E-MAILED
Friday, September 27, 2019NON-FINAL ACTION WRITTEN
Thursday, September 26, 2019ASSIGNED TO EXAMINER
Wednesday, September 25, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 23, 2019ASSIGNED TO LIE
Monday, September 16, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 19, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 15, 2019NEW APPLICATION ENTERED

Related Keywords

therapeutics cyteir synthetic medical research lethality services therapies testing repair oncology scientific